文明病藥物市場：依治療類型、劑型及分佈分類－2025-2030年全球預測

文明病藥物市場規模2023年為209.4億美元，預估2024年將達221.4億美元，複合年成長率為5.82%，2030年將達311.2億美元。

文明病是指旨在透過治療不危及生命的主觀症狀（例如勃起功能障礙、肥胖、憂鬱症和戒菸）來改善生活品質的藥物。這些藥物滿足了重視個人福祉和進步的社會的需求，並為醫學和文化轉型鋪平了道路。全球對日常生活中藥物增強的接受度不斷提高，加上生活方式帶來的壓力、不良飲食習慣和久坐習慣，推動了對治療與文明病的藥物的需求。應用主要包括心血管、性功能障礙、心理健康和皮膚科，最終用途著重於便利性，例如醫院、診所和個人家庭使用。市場成長受到健康意識提高、可支配收入增加以及給藥方法技術進步的顯著影響。最近潛在的商機源於對個人化醫療和遠端醫療的快速成長的興趣。然而，監管監督、道德考慮以及與文明病藥物被視為非必需品或奢侈品的風險等限制因素可能會限制市場滲透。此外，圍繞著使用這些藥物的社會和文化恥辱以及潛在的副作用對市場成長構成了進一步的挑戰。創新領域包括開拓環保和生物基藥物配方、人工智慧驅動的標靶藥物傳輸以及整合行動醫療應用程式以進行全面的生活方式管理。在消費者趨勢和技術採用的推動下，市場格局是動態的，這表明前景廣闊但競爭激烈。企業必須投資消費者教育計劃並與數位健康平台建立策略夥伴關係關係，以有效地進入這個不斷擴大的市場。

市場動態：快速發展的文明病治療市場的關鍵市場洞察

由於供需的動態互動，文明病治療藥物市場正在經歷轉型。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

• 市場促進因素
  • 不健康的飲食習慣和久坐的生活方式根深蒂固
  • 個人健身和健康意識不斷增強
  • 性功能障礙和荷爾蒙失衡的增加
• 市場限制因素
  • 產品高成本
• 市場機會
  • 增加藥物開發的研究和開發
  • 美容和護膚治療支出增加
• 市場挑戰
  • 與文明病藥物相關的副作用

波特五力：駕馭文明病藥物市場的策略工具

波特的五力架構是了解文明病藥物市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解文明病治療藥品市場的外部影響

外部宏觀環境因素在塑造文明病藥物市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解文明病治療藥物市場的競爭狀況

對文明病治療藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV文明病藥物市場供應商的定位矩陣績效評估

FPNV定位矩陣是評估文明病醫學市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪文明病治療藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，與文明病藥物市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 採取不健康的飲食習慣和久坐的生活方式
    • 個人健身和健康意識不斷增強
    • 性功能障礙和荷爾蒙失衡增加
  • 抑制因素
    • 產品成本高
  • 機會
    • 加強藥物研發的研究與開發
    • 美容和護膚治療支出增加
  • 任務
    • 與文明病藥物相關的不良反應
• 市場區隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 經濟
  • 社群
  • 技術的
  • 合法地
  • 環境

第6章依治療類型文明病藥物市場

• 皮膚科
• 失眠
• 肥胖
• 性功能障礙
• 吸煙
• 婦女健康

第7章文明病治療藥物市場：依形式

• 奶油
• 凝膠
• 口服糖漿
• 藥片

第8章文明病治療藥品市場經銷商

• 醫院藥房
• 線上管道
• 零售藥房

第9章 北美和南美文明病治療藥物市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太地區文明病藥物市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章 歐洲、中東和非洲文明病治療藥物市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭格局

• 2023 年市場佔有率分析
• FPNV 定位矩陣，2023
• 競爭情境分析
• 戰略分析和建議

公司名單

• Alembic Pharmaceuticals Limited
• Amgen, Inc.
• AstraZeneca Plc
• Biocon Limited
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• Eli Lilly and Company
• GlaxoSmithKline Plc
• Johnson & Johnson Services, Inc.
• Lupin Limited
• Merck KGaA
• Novo Nordisk A/S
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• The Procter & Gamble Company
• Viatris Inc.

The Lifestyle Drugs Market was valued at USD 20.94 billion in 2023, expected to reach USD 22.14 billion in 2024, and is projected to grow at a CAGR of 5.82%, to USD 31.12 billion by 2030.

Lifestyle drugs refer to pharmaceuticals designed to improve the quality of life by treating non-life-threatening and often subjective conditions such as erectile dysfunction, obesity, depression, and smoking cessation. These drugs cater to the demands driven by the societal emphasis on personal well-being and enhancement, paving the way for both medical and cultural shifts. The necessity of lifestyle drugs is fueled by an increasing global acceptance of pharmaceutical enhancements in daily life, combined with lifestyles that contribute to stress, poor diets, and sedentary habits. Applications primarily span across cardiovascular health, sexual dysfunction, mental health, and dermatology, with the end-use scope including hospitals, clinics, and personal use at home, emphasizing convenience. Market growth is significantly influenced by rising health awareness, increasing disposable incomes, and technological advancements in drug delivery methods. Recent potential opportunities emerge from the rapidly growing interest in personalized medicine and telehealth, which can facilitate custom lifestyle management plans, expanding reach within previously untapped demographics. However, limitations include regulatory scrutiny, ethical considerations, and the risk of lifestyle drugs being perceived as non-essential or luxury items, which may limit market penetration. Furthermore, societal and cultural stigma surrounding the use of these drugs, alongside potential side effects, pose additional challenges to market growth. Innovative areas ripe for exploration include the development of eco-friendly and bio-based drug formulas, leveraging AI for targeted drug delivery, and integrating mobile health apps for comprehensive lifestyle management. The nature of the lifestyle drugs market is dynamic, driven by consumer trends and technological adoption, suggesting a promising yet competitive landscape. It's crucial for businesses to invest in consumer education initiatives and forge strategic partnerships with digital health platforms to effectively tap into this expanding market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Lifestyle Drugs Market

The Lifestyle Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Adoption of unhealthy eating habits and sedentary lifestyle
  • Increasing awareness regarding personal fitness and health consciousness
  • Rise in sexual disorders and hormonal imbalance
• Market Restraints
  • High cost of products
• Market Opportunities
  • Increasing R&D for drug developments
  • Rising expenditure on beauty and skin care therapeutics
• Market Challenges
  • Adverse effects associated with the lifestyle drugs

Porter's Five Forces: A Strategic Tool for Navigating the Lifestyle Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Lifestyle Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Lifestyle Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Lifestyle Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Lifestyle Drugs Market

A detailed market share analysis in the Lifestyle Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Lifestyle Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Lifestyle Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Lifestyle Drugs Market

A strategic analysis of the Lifestyle Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lifestyle Drugs Market, highlighting leading vendors and their innovative profiles. These include Alembic Pharmaceuticals Limited, Amgen, Inc., AstraZeneca Plc, Biocon Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson Services, Inc., Lupin Limited, Merck KGaA, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceutical Industries Ltd., The Procter & Gamble Company, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Lifestyle Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Therapeutic Type, market is studied across Dermatology, Insomnia, Obesity, Sexual Dysfunction, Smoking, and Women's Health.
• Based on Form, market is studied across Creams, Gels, Oral Syrups, and Tablets.
• Based on Distribution, market is studied across Hospital Pharmacies, Online Channels, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Adoption of unhealthy eating habits and sedentary lifestyle
    • 5.1.1.2. Increasing awareness regarding personal fitness and health consciousness
    • 5.1.1.3. Rise in sexual disorders and hormonal imbalance
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of products
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing R&D for drug developments
    • 5.1.3.2. Rising expenditure on beauty and skin care therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse effects associated with the lifestyle drugs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Lifestyle Drugs Market, by Therapeutic Type

• 6.1. Introduction
• 6.2. Dermatology
• 6.3. Insomnia
• 6.4. Obesity
• 6.5. Sexual Dysfunction
• 6.6. Smoking
• 6.7. Women's Health

7. Lifestyle Drugs Market, by Form

• 7.1. Introduction
• 7.2. Creams
• 7.3. Gels
• 7.4. Oral Syrups
• 7.5. Tablets

8. Lifestyle Drugs Market, by Distribution

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Online Channels
• 8.4. Retail Pharmacies

9. Americas Lifestyle Drugs Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Lifestyle Drugs Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Lifestyle Drugs Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alembic Pharmaceuticals Limited
• 2. Amgen, Inc.
• 3. AstraZeneca Plc
• 4. Biocon Limited
• 5. Cipla Limited
• 6. Dr. Reddy's Laboratories Ltd.
• 7. Eli Lilly and Company
• 8. GlaxoSmithKline Plc
• 9. Johnson & Johnson Services, Inc.
• 10. Lupin Limited
• 11. Merck KGaA
• 12. Novo Nordisk A/S
• 13. Pfizer Inc.
• 14. Teva Pharmaceutical Industries Ltd.
• 15. The Procter & Gamble Company
• 16. Viatris Inc.

LIST OF FIGURES

• FIGURE 1. LIFESTYLE DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. LIFESTYLE DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL LIFESTYLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. LIFESTYLE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. LIFESTYLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. LIFESTYLE DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL LIFESTYLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. LIFESTYLE DRUGS MARKET DYNAMICS
• TABLE 7. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SEXUAL DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SMOKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY WOMEN'S HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ORAL SYRUPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 35. CANADA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CHINA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 52. CHINA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 55. INDIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ITALY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 107. ITALY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 118. POLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 119. POLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 121. QATAR LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 122. QATAR LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 150. LIFESTYLE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. LIFESTYLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023